8BZD
| deAc-FC stabilizer of 14-3-3 and ERalpha | 分子名称: | 14-3-3 protein sigma, De-acetylated Fusicoccin, ERalpha peptide, ... | 著者 | Visser, E.J, Ottmann, C. | 登録日 | 2022-12-14 | 公開日 | 2024-06-26 | 実験手法 | X-RAY DIFFRACTION (1.5 Å) | 主引用文献 | Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer To Be Published
|
|
8BZE
| FC-J stabilizer for ERa and 14-3-3 | 分子名称: | (2~{S},3~{R},4~{S},5~{S},6~{R})-2-[[(1~{E},3~{R},4~{S},8~{R},9~{R},10~{R},11~{S},14~{S})-14-(methoxymethyl)-3,10-dimethyl-4,9-bis(oxidanyl)-6-propan-2-yl-8-tricyclo[9.3.0.0^{3,7}]tetradeca-1,6-dienyl]oxy]-6-(2-methylbut-3-en-2-yloxymethyl)oxane-3,4,5-triol, 14-3-3 protein sigma, ERalpha peptide, ... | 著者 | Visser, E.J, Ottmann, C. | 登録日 | 2022-12-14 | 公開日 | 2024-06-26 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.43 Å) | 主引用文献 | Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a new potential intervention strategy for endocrine resistance in breast cancer To Be Published
|
|
8BZG
| FC-31 stabilizer of 14-3-3 and ERalpha | 分子名称: | 14-3-3 protein sigma, ERalpha peptide, Fusicoccin 31, ... | 著者 | Visser, E.J, Ottmann, C. | 登録日 | 2022-12-14 | 公開日 | 2024-06-26 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.49 Å) | 主引用文献 | Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer To Be Published
|
|
8BZT
| FC-NAg stabilizer of 14-3-3 and ERalpha | 分子名称: | 14-3-3 protein sigma, ERalpha peptide, MAGNESIUM ION, ... | 著者 | Visser, E.J, Ottmann, C. | 登録日 | 2022-12-15 | 公開日 | 2024-06-26 | 実験手法 | X-RAY DIFFRACTION (1.65 Å) | 主引用文献 | Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer To Be Published
|
|
8C0L
| FC-THF stabilizer of 14-3-3 and ERalpha | 分子名称: | 14-3-3 protein sigma, ERalpha peptide, Fusicoccin A-THF | 著者 | Visser, E.J, Ottmann, C. | 登録日 | 2022-12-17 | 公開日 | 2024-07-10 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Stabilization of the Estrogen receptor alpha - 14-3-3 interaction as a potential intervention strategy for endocrine resistance in breast cancer To Be Published
|
|
5LU2
| Human 14-3-3 sigma complexed with long HSPB6 phosphopeptide | 分子名称: | 14-3-3 protein sigma, Heat shock protein beta-6 | 著者 | Sluchanko, N.N, Beelen, S, Kulikova, A.A, Weeks, S.D, Antson, A.A, Gusev, N.B, Strelkov, S.V. | 登録日 | 2016-09-07 | 公開日 | 2017-02-01 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator. Structure, 25, 2017
|
|
5LX2
| |
8DP5
| Structure of the PEAK3/14-3-3 complex | 分子名称: | 14-3-3 protein beta/alpha, 14-3-3 protein epsilon, Protein PEAK3, ... | 著者 | Torosyan, H, Paul, M, Jura, N, Verba, K.A. | 登録日 | 2022-07-14 | 公開日 | 2023-06-28 | 最終更新日 | 2024-10-30 | 実験手法 | ELECTRON MICROSCOPY (3.1 Å) | 主引用文献 | Structural insights into regulation of the PEAK3 pseudokinase scaffold by 14-3-3. Nat Commun, 14, 2023
|
|
5MHC
| Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide | 分子名称: | 14-3-3 protein sigma, CALCIUM ION, LYS-LEU-MET-PHE-LYS-TPO-GLU-GLY-PRO-ASP-SER-ASP, ... | 著者 | Andrei, S, Ottmann, C, Leysen, S. | 登録日 | 2016-11-24 | 公開日 | 2017-10-04 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | 主引用文献 | Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction. FEBS Lett., 591, 2017
|
|
5MYC
| Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS910 | 分子名称: | 14-3-3 protein sigma, CALCIUM ION, CHLORIDE ION, ... | 著者 | Stevers, L.M, de Vries, R.M.J.M, Ottmann, C. | 登録日 | 2017-01-26 | 公開日 | 2017-03-01 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.459 Å) | 主引用文献 | Structural interface between LRRK2 and 14-3-3 protein. Biochem. J., 474, 2017
|
|
5MOC
| Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide | 分子名称: | 14-3-3 protein sigma, CHLORIDE ION, MAGNESIUM ION, ... | 著者 | Andrei, S, Ottmann, C, Leysen, S. | 登録日 | 2016-12-14 | 公開日 | 2017-10-04 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction. FEBS Lett., 591, 2017
|
|
5MXO
| Crystal structure of 14-3-3sigma and a p53 C-terminal 12-mer synthetic phosphopeptide stabilized by Fusicoccin-A | 分子名称: | 14-3-3 protein sigma, CHLORIDE ION, FUSICOCCIN, ... | 著者 | Andrei, S, Ottmann, C, Leysen, S. | 登録日 | 2017-01-24 | 公開日 | 2017-11-08 | 最終更新日 | 2024-10-16 | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | 主引用文献 | Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction. FEBS Lett., 591, 2017
|
|
5MY9
| Crystal structure of human 14-3-3 sigma in complex with LRRK2 peptide pS935 | 分子名称: | 14-3-3 protein sigma, CALCIUM ION, CHLORIDE ION, ... | 著者 | Stevers, L.M, de Vries, R.M.J.M, Ottmann, C. | 登録日 | 2017-01-26 | 公開日 | 2017-03-01 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (1.327 Å) | 主引用文献 | Structural interface between LRRK2 and 14-3-3 protein. Biochem. J., 474, 2017
|
|
5N5T
| 14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV2 | 分子名称: | 14-3-3 protein sigma, 4-[3,5-bis(chloranyl)pyridin-2-yl]oxyphenol, CHLORIDE ION, ... | 著者 | Sijbesma, E, Leysen, S, Ottmann, C. | 登録日 | 2017-02-14 | 公開日 | 2017-07-19 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening. Biochemistry, 56, 2017
|
|
8DGM
| 14-3-3 epsilon bound to phosphorylated PEAK1 (pT1165) peptide | 分子名称: | 1,2-ETHANEDIOL, 14-3-3 protein epsilon, Inactive tyrosine-protein kinase PEAK1 | 著者 | Roy, M.J, Hardy, J.M, Lucet, I.S. | 登録日 | 2022-06-24 | 公開日 | 2023-06-07 | 最終更新日 | 2023-10-25 | 実験手法 | X-RAY DIFFRACTION (3.2 Å) | 主引用文献 | Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. Nat Commun, 14, 2023
|
|
8DGN
| |
8DGP
| 14-3-3 epsilon bound to phosphorylated PEAK3 (pS69) peptide | 分子名称: | 1,2-ETHANEDIOL, 14-3-3 protein epsilon, Phosphorylated PEAK3 (pS69) peptide, ... | 著者 | Roy, M.J, Hardy, J.M, Lucet, I.S. | 登録日 | 2022-06-24 | 公開日 | 2023-06-07 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling. Nat Commun, 14, 2023
|
|
5M37
| The molecular tweezer CLR01 stabilizes a disordered protein-protein interface | 分子名称: | (1R,5S,9S,16R,20R,24S,28S,35R)-3,22-Bis(dihydroxyphosphoryloxy)tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2(23),3,6,8(17),10,12,14,18,21,25,27(36),29,31,33,37-pentadecaene, 14-3-3 protein zeta/delta, BENZOIC ACID, ... | 著者 | Bier, D, Ottmann, C. | 登録日 | 2016-10-14 | 公開日 | 2017-11-15 | 最終更新日 | 2024-11-06 | 実験手法 | X-RAY DIFFRACTION (2.35 Å) | 主引用文献 | The Molecular Tweezer CLR01 Stabilizes a Disordered Protein-Protein Interface. J. Am. Chem. Soc., 139, 2017
|
|
5N10
| |
5N5W
| 14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV3 | 分子名称: | 14-3-3 protein sigma, 4-[3,5-bis(chloranyl)pyridin-2-yl]oxyaniline, CALCIUM ION, ... | 著者 | Sijbesma, E, Leysen, S, Ottmann, C. | 登録日 | 2017-02-14 | 公開日 | 2017-07-19 | 最終更新日 | 2024-11-13 | 実験手法 | X-RAY DIFFRACTION (1.37 Å) | 主引用文献 | Identification of Two Secondary Ligand Binding Sites in 14-3-3 Proteins Using Fragment Screening. Biochemistry, 56, 2017
|
|
5LU1
| Human 14-3-3 sigma CLU3 mutant complexed with short HSPB6 phosphopeptide | 分子名称: | 14-3-3 protein sigma, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, Heat shock protein beta-6 | 著者 | Sluchanko, N.N, Beelen, S, Kulikova, A.A, Weeks, S.D, Antson, A.A, Gusev, N.B, Strelkov, S.V. | 登録日 | 2016-09-07 | 公開日 | 2017-02-01 | 最終更新日 | 2024-10-09 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator. Structure, 25, 2017
|
|
8EQ8
| |
8EQH
| |
5LVZ
| |
5M35
| |